Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.82
+0.00 (0.00%)
AAPL  271.86
+0.00 (0.00%)
AMD  214.16
+0.00 (0.00%)
BAC  55.00
+0.00 (0.00%)
GOOG  313.80
+0.00 (0.00%)
META  660.09
+0.00 (0.00%)
MSFT  483.62
+0.00 (0.00%)
NVDA  186.50
+0.00 (0.00%)
ORCL  194.91
+0.00 (0.00%)
TSLA  449.72
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.